top of page

Invested in Puncture

Devoted to improving puncture,  addressing current technical limitations, enabling delivery of future medicines and improved patient experience and outcomes.

About US

We are an NSF sponsored company focused on improving puncture.  Our team collectively brings 75+ years of industry experience across diverse business areas ranging from R&D medical device engineering to legal with emphasis on building stratetic patent portfolios. 

NSF_Official_logo_CMYK.png
Two Spheres

Opportunities

I. Immediate Opportunity: Industry Partner for Phase II NSF

gNu Technologies' is seeking an Industry Partner for our Phase II NSF SBIR.  Receipt of this award will result in $1.2 to $1.7M in funding.  We will use this funding to:

  • Advance our technology to FDA pre-submission

  • Identify additional market opportunities

  • Expand understanding of our technology across other platforms

​

II. Ongoing Opportunity: Investors, Licensing, & Partners

gNu Technologies' is seeking an Investors, Licensors, and Partners to advance our technology to market.  We are specifically seeking those working in spaces such as, but not limited to: 

  • Autoinjectors

  • Safety Syringes

  • Drug Developers and Companies (notably with high viscosity drugs for injection)

  • Specialized needles (e.g., dermal injectors)

Our Focus & Technology

gNu Technologies' patent pending innovations provide benefits not previously available by traditional hypodermic needles such as: 

  • Increased flow rate during drug delivery 

  • Increased volume of drug

  • Decreased dwell time

  • Decreased patient discomfort

  • Comparative cost to traditional hypodermic needles

​

Silver Sphere
bottom of page